If you’re searching for the best Cefixime brand name in India, you’ve come to the right place. In this article, we provide a comprehensive list of the best Cefixime tablet in India, their pricing, manufacturers, and key differentiators. This guide will help doctors, pharmacists, and patients choose the right Cefixime brand based on effectiveness, affordability, and market reputation.
Cefixime is a third-generation cephalosporin antibiotic extensively used in India to treat various bacterial infections. Its efficacy against both Gram-positive and Gram-negative bacteria has led to the availability of numerous brands in the Indian pharmaceutical market.
ALSO READ: Best cough syrup names in India 2023
Top Cefixime Brands in India 2025:
Below is a curated list of some of the leading cefixime brands in India, along with their respective manufacturers and approximate Maximum Retail Prices (MRPs):
| Sr. No. | Product Name | Company Name | MRP (INR) |
| 1 | Zifi 200 | FDC Limited | ₹109.53for 10 tablets |
| 2 | Cefix 200 | Cipla Ltd. | ₹109.53 for 10 tablets |
| 3 | Mahacef 200 | Mankind Pharma | ₹103.93 for 10 tablets |
| 4 | Taxim-O 200 | Alkem Laboratories | ₹109.49 for 10 tablets |
| 5 | Safexim 200 | Abbott India | ₹119.31for 10 tablets |
| 6 | Ceffon 200 | Laafon Galaxy Pharmaceuticals | ₹131 for 10 tablets |
| 7 | Cefiglan 200 | Glenmark Pharmaceuticals | ₹74.19 for 10 tablets |
| 8 | Ceftas 200 | Intas Pharmaceuticals | ₹104.10 for 10 tablets |
| 9 | Raxim-O 200 | Zydus Cadila | ₹84.8 for 10 tablets |
| 10 | Ziprax 200 | Cipla Ltd. | ₹109.53 for 10 tablets |
Why are these products the best?
The prominence of these brands can be attributed to several factors:
Clinical Efficacy: Clinical outcomes and patient feedback have reinforced the efficacy of these brands in treating bacterial infections, leading to their sustained popularity. Most of the doctors in the country prescribe these 10 brands to their patients.
Market Share and Demand: Brands like Zifi and Taxim-O have established a strong market presence due to consistent demand and widespread prescriptions by healthcare professionals. According to FDC’s report, Zifi has a 25.4% market share in India in Cefixime product sales, while Taxim-O has a 22.8 % share in the same period.
Quality Manufacturing Practices: Companies such as FDC Limited, Cipla, Zydus Cadila, Laafon Galaxy, and Alkem Laboratories adhere to stringent manufacturing protocols, ensuring high-quality products.
Regulatory Approvals: Many of these brands are produced in facilities compliant with USFDA, and WHO-GMP standards, underscoring their commitment to quality and safety.
The Indian cefixime market has witnessed steady growth, driven by the increasing prevalence of bacterial infections and the demand for effective oral antibiotics. According to a report by TechSci Research, the market is expected to continue its upward trajectory in the coming years.
Dosage of Cefixime
Cefixime Usage Guidelines:
- Dosage Forms Available
1. Tablets: 100 mg, 200 mg, 400 mg
2. Oral Suspension for Pediatric Use 50mg and 100mg/5mg - Recommended Dosage: (As per doctor’s prescription)
Schedule Category of Cefixime in India
Cefixime is a Schedule H1 Drug category in India as per Drug. and Cosmetic Act 1940. Not only Zifi tablets but Zifi Dry syrup 50 mg and 100 mg were also sold most in this molecule category.
Cefixime Safety Warnings
- Avoid alcohol while on medication
- Do not use in penicillin-allergic patients
- Complete the full course to prevent antibiotic resistance
History of Cefixime:
Wyeth sold cefixime under the brand name Suprax 125 until 2003. After the drug manufacturer’s patent expired, Lupin grabbed the · Suprax brand and sold it until 2007 in the US. Then, it started selling it in different strengths, such as 50mg, 100mg, 200mg, and 400mg.
In the United States, cefixime was sold under a few brands Taximo, Ofex, Pancef, Caricef, Texit, Cef-3, Fix-A, and Zifi.
In India Cefixime is sold under thousands of brands due to a large number of manufacturing companies in India. The top 10 •famous brands in India are Zifi, Ceffon, Ziprax, Taxim-O, Mahacef, Cefix, etc.
Cefixime tablets IP 200 mg price in India
In India, the price of cefixime tablets and oral suspensions is controlled by NPPA, In Order No. SO 4663(E) dated 25.10.2023 the Price of Cefixime 200 mg tablet is Rs. 9.78 per tablet, Cefixime 400 mg tablet is Rs. 22.1 per tablet, Cefixime Oral Liquid 100 mg/5ml at Rs. 2.16 per ml, Cefixime Oral Liquid 50 mg/ 5ml at Rs. 1.63 per ml, GST is extra from this price.Â
ALSO READ:Â Pharmaceutical formulation plants for sale in North India
The working mechanism of Cefixime;
Cefixime binds to penicillin-binding proteins (PBPs) that inhibit the final transpeptidation step to the peptidoglycan synthesis in the bacterial cell wall, therefore promoting biosynthesis and arresting Call wall assembly results in the bacteria cell death.
The action of the mechanism of cefixime is because of the Inhibition of bacteria cell wall Synthesis.
FAQs
Which is the best cefixime brand in India?
Zifi 200, Taxim-O, and Cefix 200 are among the most prescribed and widely trusted brands.
Can I buy cefixime without a prescription in India?
No, cefixime is a prescription-only antibiotic categorized in Schedule H1 of the Drug Act in India and should be taken under a doctor’s guidance.
Conclusion:
The diverse range of cefixime brands available in India offers healthcare professionals multiple options to effectively treat bacterial infections. The brands listed above have distinguished themselves through quality, efficacy, and market acceptance, making them reliable choices in clinical practice.
References:
- Investors Presentation-FDC Limited
- Report on Cefixime consumption-TechSciResearch
Medically Reviewed by:
Dr. Yogesh Chaudhary (B. Pharma)
Senior Pharmacist at S.N. Medical College, Agra-(UP)
Disclaimer:
Disclaimer: All the information and articles available on this site are for educational purposes only. The information given here should not be used for the diagnosis or treatment of any health problem or disease without expert advice. The advice of a qualified medical practitioner should always be sought for medical examination and treatment. Further, the information provided is for educational purposes only and should not be a substitute for professional medical advice.
